DERM Rasio cepet Journey Medical Corp

Journey Medical (DERM) is a manufacturer of dermatological products facing stringent FDA oversight and competition from affordable generics, as illustrated by the current stock price chart on GURU.Markets. Business profits may decline due to narrow specialization and marketing expenses, although the current figure stands at 1.37. Increased sales of specialized medications have allowed the company to stabilize liquidity and halt the intensive cash burn.

The ratio is calculated as the most liquid assets divided by short-term liabilities, intentionally excluding inventory. This metric determines the issuer's ability to instantly settle debts relying solely on cash and accounts receivable. For Journey Medical (DERM), which is subject to FDA pricing regulations in the dermatological segment, such a check is critical for assessing financial stability. The current quick ratio of 1.37 demonstrates the business's real margin of safety.